10199-SPDR-2 PERSONALIZED SYNTHETIC LETHALITY INDUCED BY TARGETING ATR-CHK1 IN MEDULLOBLASTOMAS IDENTIFIED BY IMPLEMENTATION OF SLFN11 IMMUNOHISTOCHEMISTRYSatoshi Nakata, Masahiko Tosaka, Hideaki Yashima et al.|Neuro-Oncology Advances|2023Cited by 0